• OPEN AN ACCOUNT
Indian Indices
Nifty
24,870.10 -213.65
(-0.85%)
Sensex
81,306.85 -693.86
( -0.85%)
Bank Nifty
55,149.40 -606.05
( -1.09%)
Nifty IT
35,440.85 -283.05
( -0.79%)
Global Indices
Nasdaq
45,658.64 852.13
(1.90%)
Dow Jones
6,488.44 97.27
(1.52%)
Hang Seng
42,587.47 -22.70
(-0.05%)
Nikkei 225
9,321.40 12.20
(0.13%)
Forex
USD-INR
87.17 0.12
(0.14%)
EUR-INR
101.39 0.01
(0.01%)
GBP-INR
117.16 -0.12
(-0.11%)
JPY-INR
0.59 0.00
(-0.18%)

EQUITY - MARKET SCREENER

Deepak Nitrite Ltd
Industry :  Chemicals
BSE Code
ISIN Demat
Book Value()
506401
INE288B01029
229.2256691
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DEEPAKNTR
101.05
24629.17
EPS(TTM)
Face Value()
Div & Yield %
17.87
2
0.42
 

Gennex Laboratories Ltd - Board Meeting Outcome for Board Meeting Held On July 04 2025 For Conversion Of 60 Lacs Warrants Into Equity Shares
Jul 04,2025
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11 2024 we wish to inform you that Board of Directors of the Company at its meeting held today on July 04 2025 has considered and approved the following: 1. Allotment of 6000000 Equity Shares upon Conversion of Warrants to the member of promoter group on Preferential basis. The requisite disclosures are set out in Annexure A to this letter. We hereby submit that the Board Meeting had commenced at 02:00 PM and concluded at 02.40 PM. This intimation is also uploaded on the Company website: www.gennexlab.com We request you to take the above information on record and acknowledge the receipt of the same.